LUCD logo
LUCD
Lucid Diagnostics

Medicare Coverage And Health Partnerships Will Unlock Future Potential

Published
12 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$3.63
69.7% undervalued intrinsic discount
15 Aug
US$1.10
Loading
1Y
34.3%
7D
7.8%

Author's Valuation

US$3.6

69.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates3

Shared on01 May 25
Fair value Decreased 0.41%

Read more

Shared on24 Apr 25
Fair value Decreased 4.00%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25

Read more